JPMorgan upgraded Dynavax Technologies (NASDAQ: DVAX) from Neutral to Overweight with a price target of $27.00 (from $25.00).Analyst Anupam ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE